Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02935361
Brief Title: Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

First Submitted : October 13, 2016
First Submitted that Met QC Criteria : October 13, 2016
First Posted : October 17, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 1, 2021
Last Update Posted : April 6, 2021